# Bad Blood: A Diagnostic of Modern Startup Risk

> Carreyrou turns investigative reporting into a set of diagnostic tools for reading startup claims and promises. The book teaches you how to test narratives, surface incentives, and prioritize evidence over charisma.

- **Author**: Blookmark
- **Published**: 2025-05-06T19:12:21
- **Canonical URL**: https://www.blookmark.com/book-reviews/bad-blood-a-diagnostic-of-modern-startup-risk

## Content

## Relevant For:

- Investors deciding how to underwrite breakthrough claims

- Founders and operators building governance and testing disciplines

- Journalists and auditors who verify evidence against narrative

- Regulators and compliance officers evaluating systemic risk

## Remarkable Points:

- Reporting as a method: the book models persistent, skeptical evidence-gathering rather than episodic exposure.

- Narrative laundering: PR and charismatic leadership can convert uncertainty into perceived certainty without new data.

- Secrecy beats scrutiny: enforced opacity substitutes for rigorous validation and accelerates failure modes.

- Incentives warp truth: prestige, fear, and financial upside systematically suppress dissent.

Whistleblower dynamics matter: internal actors with access plus moral calculus change outcomes.

## Most Liked (As-Is Statements):

"Relentless reporting that pierced Silicon Valley's polish."

"A compact manual on how to interrogate technological claims."

"Shows how charisma substitutes for verification and why that is dangerous."

## Key Themes:

### Theme 1: Incentive Architecture

Bad Blood illustrates how compensation, reputation, and silence create feedback loops that favor illusion over truth. The core lesson: align rewards with verifiable outcomes, not with narratives.

### Theme 2: Evidence Over Story

Carreyrou emphasizes testable claims. When a technology cannot be independently validated, the story becomes the product and investors buy fiction dressed as progress.

### Theme 3: Organizational Opacity

Secrecy functions as a control mechanism. The book shows how restricted access and layered approvals hide failures until they are catastrophic.

### Theme 4: The Role of Gatekeepers

Board members, investors, journalists and regulators either amplify falsehoods or correct them. The work examines how each gatekeeper failed and how they can be reformed.

## Final Remark:

Bad Blood is not primarily a narrative about a single fraud. It is a compact playbook for spotting systemic warning signs in high-stakes innovation. The value is tactical: it equips readers to replace faith with simple tests, to spot when charisma is obscuring evidence, and to redesign incentives so truth is a natural outcome. The book leaves you with practical mental models rather than trivia about a scandal.

***Read this book to learn how to separate plausible promises from provable claims.***

## Similar Books:

- Bad Pharma by Ben Goldacre

- Big Pharma by Jacky Law

- [Black Edge](/book-reviews/black-edge-a-minimalist-manual-on-power-information-and-enforcement) by Sheelah Kolhatkar

- [The Smartest Guys in the Room](/book-reviews/collective-blindness-at-scale-the-smartest-guys-in-the-room) by Bethany McLean and Peter Elkind